Recruiting
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring - IM047-003
Zaktualizowano:
26 luty, 2024
|
ClinicalTrials.gov
Płeć
Zakres wieku
Lokalizacje
Recruiting
Inclusion Criteria: - Diagnosis of Multiple sclerosis (MS) - Currently or recently pregnant - Reside in a country where ozanimod is prescribed for treatment of MS Exclusion Criteria: - Diagnostic prenatal test results known prior to first contact with the Registry Coordination Center (RCC) - Exposure to known teratogens and/or investigational medications during pregnancy Other protocol-defined inclusion/exclusion criteria apply